Genetics likely determine who benefits from vitamins in the developed world

In 1911, Polish biochemist Casimir Funk discovered what was behind a then-mysterious neurological condition known as beriberi, common in regions where people’s main source of calories came from de-husked, or ‘polished,’ rice.

He fed a group of ill pigeons a substance he had isolated from rice polishings, and within 12 hours, they had recovered. Funk went on to propose that a handful of puzzling ailments including beriberi and scurvy arose because of deficiencies in nutrients like the one he had found in the rice husks. He considered these chemicals vital amines, which he shortened to “vitamines.”

Today, nobody doubts that vitamin B1 can prevent beriberi or that vitamin C prevents scurvy. But scientific opinion about the use of vitamin supplements by millions of seemingly healthy people has never been more divided. An important factor is genetic variability.

“Every person has about 50,000 variations in their genes,” says Steven Zeisel, director of the University of North Carolina Nutrition Research Institute in Chapel Hill. Any number of them could be important in metabolism. Yet “very few geneticists are collecting diet information, and very few diet people collect genetic information”.

Zeisel’s work has uncovered, for example, that 44 percent of women have gene variants that significantly increase their dietary requirements for the nutrient choline. It is perhaps no wonder that trial results have been inconsistent.

Read the full, original story: Nutrition: Vitamins on trial

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
Screenshot 2026-05-06 at 2.56
Singularity crisis ahead? Can super babies save us from rogue AI geniuses?
Screenshot-PM-24
Viewpoint: The herbicide glyphosate isn’t perfect. Banning it would be far worse.
images
The never-ending GMO debate: Pros and cons
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom
ChatGPT-Image-May-1-2026-02_20_13-PM
How RFK, Jr.’s false vaccine claims are holding up $600 million to fight diseases in poor countries
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.